Aptevo Therapeutics Inc. (APVO)
Market Closed
16 Jun, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
4. 54
-0.16
-3.4043%
$
10.45M Market Cap
- P/E Ratio
- Div Yield
13,471 Volume
-1.71 Eps
$ 4.7
Previous Close Want to track APVO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
APVO Earnings Reports FAQ
What is the earnings per share (EPS) for APVO?
The current EPS is -1.71.
What is the company's earnings growth rate?
Aptevo Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Aptevo Therapeutics Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Aptevo Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for APVO at this time, as Aptevo Therapeutics Inc has no recent EPS data to calculate it.
